Science Explorer Interactive view Map
Company · Tokyo · Japan

ABB (Japan)

new.abb.com/jpROR OpenAlex
Research works
44
▲ 39% vs 2013–17
Citations
594
13.6 per fractional work
Top-10% rate
26.7%
record average 16.5%
Open access
65%
world 28%

Not ranked overall: ABB (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.91× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.32× its world share, 1 worksImmunology and Micro…Neuroscience: 0.59× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.33× its world share, 0 worksPharmacology, Toxico…Engineering: 0.11× its world share, 0 worksEngineeringDentistry: 1.12× its world share, 0 worksDentistryHealth Professions: 1.03× its world share, 0 worksHealth ProfessionsMedicine: 3.26× its world share, 6 worksMedicineArts and Humanities: 1.70× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.61× its world share, 0 worksEconomics, Econometr…Psychology: 0.27× its world share, 0 worksPsychologySocial Sciences: 0.73× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.

Which keywords describe research at ABB (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Autoantibodies, Epidemiology, Inflammation, Inflammatory Bowel Disease, Cardiovascular Risk, Rheumatoid Arthritis, Cytokines and Biological Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology4▲ 2.5×24 topics
  2. Inflammation4▲ 3.4×13 topics
  3. Autoantibodies3▲ 27×4 topics
  4. Inflammatory Bowel Disease2▲ 51×4 topics
  5. Cardiovascular Risk2▲ 15×2 topics
  6. Rheumatoid Arthritis2▲ 51×2 topics
  7. Biological Therapy2▲ 90×1 topic
  8. Cytokines2▲ 19×2 topics
  9. Disease-Modifying Antirheumatic Drugs2▲ 102×1 topic
  10. Parkinson's Disease2▲ 20×5 topics
  11. Quality of Life2▲ 3.0×10 topics
  12. Genetics2▲ 5.2×5 topics
  13. Immune System2▲ 11×4 topics
  14. Immunology2▲ 30×2 topics
  15. Pathogenesis2▲ 6.6×6 topics
  16. Renewable Energy2▲ 3.6×6 topics
  17. Chemotherapy2▲ 4.9×14 topics
  18. Oxidative Stress2▲ 1.89×7 topics
  19. Regulatory T Cells2▲ 30×2 topics
  20. IL-171▲ 124×1 topic
  21. TH17 Cells1▲ 124×1 topic
  22. Treatment1▲ 2.5×11 topics
  23. Diagnostic Criteria1▲ 14×3 topics
  24. Neurological Disorders1▲ 4.4×9 topics
  25. Ankylosing Spondylitis1▲ 118×1 topic
  26. Crohn's Disease1▲ 35×2 topics
  27. Mitochondrial Dysfunction1▲ 7.6×3 topics
  28. Spondyloarthritis1▲ 118×1 topic
  29. Therapies1▲ 77×1 topic
  30. Ulcerative Colitis1▲ 77×1 topic
  31. Cancer Therapy1▲ 3.9×4 topics
  32. Immune Dysregulation1▲ 30×2 topics
  33. Immunosuppressive Therapy1▲ 13×5 topics
  34. Juvenile Idiopathic Arthritis1▲ 51×2 topics
  35. Neurodegeneration1▲ 8.4×3 topics
  36. Prognostic Factors1▲ 5.5×5 topics
  37. Sustainability1▲ 1.40×5 topics
  38. Dopaminergic Neurons1▲ 36×1 topic
  39. Emissions1▲ 12×2 topics
  40. a-Synuclein1▲ 46×1 topic

Which research topics does ABB (Japan) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, German Social Sciences and History, German Literature and Culture Studies and Dermatology and Skin Diseases.

Psoriasis: Treatment and…1Psoriasis: Treatment and Pathogenesis: 1 fractional worksGerman Social Sciences a…0German Social Sciences and History: 0 fractional worksGerman Literature and Cu…0German Literature and Culture Studies: 0 fractional worksDermatology and Skin Dis…0Dermatology and Skin Diseases: 0 fractional worksRheumatoid Arthritis Research and Therapies: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksInflammatory Bowel Disease0Inflammatory Bowel Disease: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksColorectal and Anal Carcinomas: 0 fractional works
ImmunologySociology and Political ScienceLiterature and Literary TheoryDermatology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  2. 2 German Social Sciences and History Sociology and Political Science 0 works
  3. 3 German Literature and Culture Studies Literature and Literary Theory 0 works
  4. 4 Dermatology and Skin Diseases Dermatology 0 works
  5. 5 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  6. 6 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  7. 7 Inflammatory Bowel Disease Genetics 0 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  9. 9 Asthma and respiratory diseases Physiology 0 works
  10. 10 Colorectal and Anal Carcinomas Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.8%not open35.2%

World: 28% of research is openly available.

with international co-authors41.0%domestic only59.0%

World: 19% is written across borders.

How has ABB (Japan)'s research output changed?

Output in 2018–2022 was 39% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.